Simplex Trading’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Simplex Trading’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,100	Closed	-$18K	–	10301
2023 Q4	$18K	Buy	+1,100	New	+$17.3K	﹤0.01%	7038
2022 Q3	–	Sell	-220	Closed	-$1K	–	11183
2022 Q2	$1K	Sell	220 -140	-39%	-$790	﹤0.01%	9748
2022 Q1	$2K	Buy	+360	New	+$3.53K	﹤0.01%	9981
2021 Q4	–	Sell	-430	Closed	-$18K	–	11718
2021 Q3	$18K	Hold	430	–	–	﹤0.01%	8540
2021 Q2	$18K	Buy	430 +416	+2,971%	+$23.2K	﹤0.01%	8689
2021 Q1	$104K	Hold	14	–	–	﹤0.01%	5707
2020 Q4	$59K	Buy	+14	New	+$627	﹤0.01%	6014
2020 Q3	–	Hold	0	–	–	–	7623

Simplex Trading's ORTX Position: Q4 2022 in Review

Simplex Trading sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2022, closing a stake of 187 shares — an estimated $827 sold.

Simplex Trading first reported a position in ORTX in Q2 2020 and held it in 9 quarters. The position peaked at $259K in Q2 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2022.

Simplex Trading reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 187 Orchard Therapeutics plc American Depositary Shares shares in Q4 2022, an estimated $827.
Simplex Trading first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2020 and held it in 9 quarters.
Simplex Trading's Orchard Therapeutics plc American Depositary Shares position peaked at $259K in Q2 2021.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.